Front Pharmacol. 2020 Oct 15;11:543718. doi: 10.3389/fphar.2020.543718. eCollection 2020.
ABSTRACT
Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation.
PMID:33178011 | PMC:PMC7593510 | DOI:10.3389/fphar.2020.543718